Understanding Peptides

What Are Peptides?

Peptides are short chains of amino acids, the building blocks of proteins. Your body naturally produces many peptides that act as messengers to control processes like growth, healing, and hormone release. Synthetic peptides are made in labs to mimic or influence these natural signals. They are often injected under the skin (subcutaneous) because they would be broken down if swallowed, though some (like Ibutamoren) can be taken by mouth.

Current Legal Status (as of October 2026)

In the United States, the FDA regulates drugs. Most peptides used for wellness, recovery, or anti-aging are not FDA-approved for those uses. Compounding pharmacies (special pharmacies that mix custom medications) can only prepare certain substances under strict rules (Section 503A).

Sermorelin: Formerly FDA-approved (as Geref, discontinued for commercial reasons, not safety). It is generally considered eligible for compounding on a valid prescription as a component of a previously approved drug.
CJC-1295, Ipamorelin, BPC-157, TB-500 (TB500), injectable GHK-Cu, Ibutamoren (MK-677): Not FDA-approved. Most are not currently on the list of substances pharmacies may freely compound. In 2026, FDA removed some from a “Category 2” (safety concern) list and an advisory committee recommended some (including BPC-157 and TB-500) for possible future compounding, but no final rule has been issued. Ibutamoren remains restricted due to safety concerns (including a heart-failure signal in one trial of frail elderly patients). Selling unapproved peptides for human use is illegal; “research chemical” products are not medicines.

These substances are prohibited by the World Anti-Doping Agency (WADA) for competitive athletes.

Getting High-Quality Peptides from Reputable Pharmacies vs. Other Sources

Reputable compounding pharmacies (licensed 503A pharmacies working with your doctor’s prescription):

Use pharmaceutical-grade ingredients.
Follow sterile compounding standards to reduce contamination risk.
Provide labeled products with known strength and instructions.
Are subject to state board of pharmacy oversight.

Other sources (online “research only,” gray-market, or unregulated sellers):

Are not intended for human use and are often illegal to sell for that purpose.
Frequently have purity problems, wrong dose, contaminants, or even undisclosed other drugs (e.g., steroids found in some MK-677 products).
Lack proper testing, sterile production, and medical oversight.
Carry higher risk of infection, unexpected effects, or no effect at all.

Always obtain peptides only through a licensed healthcare provider and a reputable compounding pharmacy when legally available. Never buy from unverified online sources.

Studies, Risks, and What to Consider Before Use

Available studies: Most data come from animal (mostly rodent) studies. Human evidence is limited to small pilot studies, case series, or short pharmacologic (hormone-level) studies. Large, high-quality randomized controlled trials for the common wellness or recovery claims are generally lacking.

Lacking studies: Long-term safety, optimal dosing, combination effects, benefits for muscle, fat loss, sleep, or tissue healing in healthy or injured people, and effects in specific populations (e.g., older adults, those with medical conditions).

Possible risks and complications:

Injection-site reactions (redness, swelling, pain, infection).
Unknown long-term effects; theoretical concerns about immune reactions (immunogenicity), impurities, or promoting blood-vessel growth (angiogenesis) that could theoretically affect tumors.
For growth-hormone secretagogues (CJC-1295, Ipamorelin, Sermorelin, Ibutamoren): water retention/edema, increased appetite, changes in blood sugar or insulin sensitivity, joint discomfort, and theoretical increased cancer risk from elevated IGF-1 (especially if personal or family history of cancer).
Ibutamoren specifically: trial data showed increased fat-free mass but also higher fasting glucose, reduced insulin sensitivity, and a congestive heart-failure signal that stopped a trial in hip-fracture patients.
Product-quality risks if not from a reputable source.

Before considering use, discuss with your doctor: full medical history (especially cancer, diabetes, heart disease, hormone issues), current medications, pregnancy plans, athletic status, goals, expected benefits vs. risks, need for lab monitoring (e.g., IGF-1, blood sugar, CBC), cost, and alternative evidence-based treatments. Use only under medical supervision. Stop and seek care for unusual symptoms.

Summaries of Specific Peptides

CJC-1295

A synthetic analog of growth-hormone-releasing hormone (GHRH). It stimulates the pituitary to release growth hormone (GH), which raises IGF-1. The version with DAC lasts longer. Human studies show it raises GH and IGF-1 for days after one dose, but there are no strong trials showing muscle or fat changes, and one development trial was stopped after a death (causality unclear). Limited safety data; FDA has noted concerns including heart-rate increases and vasodilatory reactions.

Ipamorelin

A selective growth-hormone secretagogue that acts on the ghrelin receptor. It stimulates GH release with less effect on cortisol or prolactin than some other agents. The only major human trial (for postoperative ileus after bowel surgery) did not meet its main goal. Often combined with CJC-1295. Limited human data for body composition.

Sermorelin

A shorter fragment of natural GHRH. It was previously FDA-approved for diagnosing and treating growth-hormone deficiency in children (Geref brand, later discontinued). It stimulates pulsatile GH release. Compounded versions are used off-label in adults. More regulatory history than most other peptides discussed here, but still not FDA-approved for anti-aging or body-composition uses.

BPC-157

A synthetic peptide derived from a protein in gastric juice. Animal studies suggest protective and healing effects on gut, tendons, muscles, and other tissues (via angiogenesis and other pathways). Human data are very limited (small uncontrolled reports of knee pain improvement; tiny safety pilots). No large controlled trials. Theoretical concerns about angiogenesis and impurities/immunogenicity.

TB500 (TB-500)

A synthetic fragment related to thymosin beta-4, involved in cell migration and tissue repair. Mostly animal data for healing. Full-length thymosin beta-4 has some human trial data for eye conditions and limited heart data, but TB-500 itself has almost none. Often paired with BPC-157 (“Wolverine” stack). Limited human safety data.

GHK-Cu

A copper-binding tripeptide (copper tripeptide-1) naturally found in the body and used in topical skincare. Small human studies of creams/serums show mixed results for skin appearance. Injectable form has essentially no published human clinical trials. Copper delivery raises additional theoretical safety questions. FDA has flagged injectable forms for potential immunogenicity concerns.

Ibutamoren (MK-677)

An oral (not a peptide) growth-hormone secretagogue that mimics ghrelin. Human trials (including a 2-year study in older adults) showed increased fat-free mass and IGF-1, but also higher blood sugar, reduced insulin sensitivity, increased appetite, and fluid retention. One trial in hip-fracture patients was stopped early due to a congestive heart-failure signal. Not FDA-approved; restricted for compounding due to safety concerns.

Formulations Available Through Reputable Pharmacies (Where Legally Compounded on Prescription)

Availability depends on current FDA rules, state pharmacy regulations, and your provider’s judgment. These are typically prepared by licensed compounding pharmacies. Always follow the specific instructions and dose prescribed for you. Routes are generally subcutaneous injection unless noted. Reconstitution (mixing powder with bacteriostatic water) may be required for some lyophilized products; your pharmacy or provider will instruct you.

Key Takeaways for Patients

Evidence for most claimed benefits is preliminary (mostly animal data).
Legal access is limited and evolving; only use products from licensed providers and reputable pharmacies.
Risks include local reactions, metabolic changes, unknown long-term effects, and product-quality issues from non-pharmacy sources.
Medical supervision, appropriate screening, and monitoring are essential.
Discuss goals, alternatives, and whether peptide therapy is appropriate for your individual situation with your healthcare team.
Report any side effects promptly.

IMPORTANT DISCLAIMER

For educational purposes only and is not medical advice. Peptide therapies are experimental or investigational for most uses discussed. Always consult your healthcare provider before starting any treatment. Regulatory status can change; information is current as of October 2026.